imclone names johnson ceo imclone systems inc named john johnson chief executive of the new york biopharmaceutical company effective aug mr johnson years old was company group chairman of johnson &amp johnsons world wide biopharmaceuticals unit he succeeds interim chief executive joseph fischer who resigned in october "we look forward to working with him to take the company to the next level " said chairman carl icahn mr icahn who owns of imclones stock installed new directors and the three man executive committee that found mr johnson 
